Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: Results of high intensity focused ultrasound;Adénocarcinome prostatique en récidive locale après radiothérapie exclusive : résultats du traitement par ultrasons focalisés

Progres en Urologie

Volumn 18, Issue 4, 2008, Pages 223-229

  Poissonnier, L ^a   Murat, F J ^a   Belot, A ^a   Bouvier, R ^a   Rabilloud, M ^a   Rouviere, O ^a   Chapelon, J Y ^b   Gelet, A ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

External beam radiotherapy; High intensity focused ultrasound; Prostate cancer

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; BRACHYTHERAPY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FOLLOW UP; FRANCE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INSTRUMENTATION; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; FRANCE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 43849112762     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2008.02.006     Document Type: Article

References (20)

1. D'Amico A.V., Cote K., Loffredo M., Renshaw A.A., and Chen M.H. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 169 (2003) 1320-1324
2. Amling C.L., Lerner S.E., Martin S.K., Slezak J.M., Blute M.L., and Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161 (1999) 857-862
3. Bianco Jr. F.J., Scardino P.T., Stephenson A.J., Diblasio C.J., Fearn P.A., and Eastham J.A. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 448-453
4. Ward J.F., Sebo T.J., Blute M.L., and Zincke H. Salvage surgery for radio recurrent prostate cancer: contemporary outcomes. J Urol 173 (2005) 1156-1160
5. Bahn D.K., Lee F., Silverman P., Bahn E., Badalament R., Kumar A., et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2 (2003) 111-114
6. Izawa J.I., Madsen L.T., Scott S.M., Tran J.P., McGuire E.J., Von Eschenbach A.C., et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. Clin Oncol 20 (2001) 2664-2671
7. Pisters L.L., von Eschenbach A.C., Scott S.M., Swanson D.A., Dinney C.P., Pettaway C.A., et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157 (1997) 921-925
8. Grado G.L., Collins J.M., Kriegshauser J.S., Balch C.S., Grado M.M., Swanson G.P., et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53 (1999) 2-10
9. Wong W.W., Buskirk S.J., Schild S.E., Prussak K.A., and Davis B.J. Combined prostate brachytherapy and short term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 176 (2006) 2020-2024
10. Gelet A., Chapelon J.Y., Poissonnier L., Bouvier R., Rouviere O., Curiel L., et al. Local recurrence of prostate cancer after external radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63 (2004) 625-629
11. Poissonnier L., Gelet A., Chapelon J.Y., Bouvier R., Rouviere O., Pangaud C., et al. Résultats du traitement par ultrasons focalisés transrectaux du cancer localisé de la prostate (120 patients avec PSA ≤ à 10 ng/ml). Prog Urol 13 (2003) 60-72
12. Chavrier F., Chapelon J.Y., Gelet A., and Cathignol D. Modeling of HIFU induced lesions in the presence of cavitation bubbles. J Acoust Soc Am 108 (2000) 432-440
13. Roach III M., Hanks G., Thames Jr. H., Dchellhammer P., Shipley W.U., Sokol G.H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
14. Swanson G.P., Riggs M., and Earle J. Failure after primary radiation or surgery for prostate cancer: differences in response to androgen ablation. J Urol 172 (2004) 525-528
15. Gaudin P.B. Histopathologic effects of radiation and hormonal therapies on benign and malignant prostate tissue. J Urol Pathol 8 (1998) 55-67
16. Cher M.L., Bianco Jr. F.J., Lam J.S., Davis L.P., Grignon D.J., Sakr W.A., et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160 (1998) 1387-1391
17. Tiguert R., Gheiler E.L., Tefilli M.V., Oskanian P., Banerjee M., Grignon D.J., et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 53 (1999) 367-371
18. Sanderson K.M., Penson D.F., Cai J., Groshen S., Stein J.P., Lieskovsky G., et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176 (2006) 2025-2031
19. Stephenson A.J., Scardino P.T., Bianco Jr. F.J., Di Blasio C.J., Fearn P.A., and Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172 (2004) 2239-2243
20. Chin J.L., Pautler S.E., Mouraviev V., Touma N., Moore K., and Downey D.B. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165 (2001) 1937-1941